The Pathology of Renal Epithelial Neoplasms

Seminars in Oncology

Volumn 33, Issue 5, 2006, Pages 534-543

  Reuter, Victor E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

ARTICLE; BIRT HOGG DUBE SYNDROME; CANCER CLASSIFICATION; CANCER GRADING; CANCER PATIENT; CHROMOSOME ARM; CLEAR CELL CARCINOMA; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; GENE LOSS; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY ADENOMA; KIDNEY BIOPSY; KIDNEY COLLECTING TUBULE; KIDNEY CYST; KIDNEY EPITHELIUM; KIDNEY FUNCTION; KIDNEY TUMOR; MEDULLARY CARCINOMA; ONCOCYTOMA; PRIORITY JOURNAL; SOMATIC MUTATION; TISSUE SECTION; TRISOMY 7; VON HIPPEL LINDAU DISEASE; X CHROMOSOME;

ADENOCARCINOMA, CLEAR CELL; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; NEOPLASMS, GLANDULAR AND EPITHELIAL;

EID: 33749433380     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2006.06.009     Document Type: Article

References (93)

1. Thöenes W., Storkel S., and Rumpelt H.J. Human chromophobe cell renal carcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol 48 (1985) 207-217
2. Thoenes W., Storkel S., and Rumpelt H.J. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 181 (1986) 125-143
3. Eble J., Sauter G., Epstein J., et al. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs (2004), IARC Press, Lyon, France
4. Kattan M.W., Reuter V., Motzer R.J., et al. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166 (2001) 63-67
5. Sorbellini M., Kattan M.W., Snyder M.E., et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 173 (2005) 48-51
6. Amin M.B., Tamboli P., Javidan J., et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: An experience of 405 cases. Am J Surg Pathol 26 (2001) 281-291
7. Cheville J.C., Lohse C.M., Zincke H., et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27 (2003) 612-624
8. Reuter V.E., and Presti Jr. J.C. Contemporary approach to the classification of renal epithelial tumors. Semin Oncol 27 (2000) 124-137
9. Fuhrman S.A., Lasky L.C., and Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 (1982) 655-663
10. Kovacs G., Erlandsson R., Boldog F., et al. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci U S A 85 (1988) 1571-1575
11. Carroll P.R., Murty V.V., Reuter V., et al. Abnormalities at chromosome region 3p12-14 characterize clear cell renal carcinoma. Cancer Genet Cytogenet 26 (1987) 253-259
12. Nordenson I., Ljungberg B., and Roos G. Chromosomes in renal carcinoma with reference to intratumor heterogeneity. Cancer Genet Cytogenet 32 (1988) 35-41
13. Walter T.A., Berger C.S., and Sandberg A.A. The cytogenetics of renal tumors. Where do we stand, where do we go?. Cancer Genet Cytogenet 43 (1989) 15-34
14. Teyssier J.R., and Ferre D. Chromosomal changes in renal cell carcinoma. No evidence for correlation with clinical stage. Cancer Genet Cytogenet 45 (1990) 197-205
15. Zbar B. Von Hippel-Lindau disease and sporadic renal cell carcinoma. Cancer Surv 25 (1995) 219-232
16. Linehan W.M., Walther M.M., and Zbar B. The genetic basis of cancer of the kidney. J Urol 170 (2003) 2163-2172
17. Linehan W.M. Molecular targeting of VHL gene pathway in clear cell kidney cancer. J Urol 170 (2003) 593-594
18. Pantuck A.J., Zeng G., Belldegrun A.S., et al. Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: Exploiting the hypoxia-induced pathway. Clin Cancer Res 9 (2003) 4641-4652
19. Kim H.L., Seligson D., Liu X., et al. Using protein expressions to predict survival in clear cell renal carcinoma. Clin Cancer Res 10 (2004) 5464-5471
20. Bui M.H., Seligson D., Han K.R., et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: Implications for prognosis and therapy. Clin Cancer Res 9 (2003) 802-811
21. Delahunt B., and Eble J.N. Papillary renal cell carcinoma: A clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 10 (1997) 537-544
22. Delahunt B., Eble J.N., McCredie M.R., et al. Morphologic typing of papillary renal cell carcinoma: Comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 32 (2001) 590-595
23. Allory Y., Ouazana D., Boucher E., et al. Papillary renal cell carcinoma. Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases. Virchows Arch 442 (2003) 336-342
24. Jiang F., Richter J., Schraml P., et al. Chromosomal imbalances in papillary renal cell carcinoma: Genetic differences between histological subtypes. Am J Pathol 153 (1998) 1467-1473
25. Delahunt B., Eble J.N., McCredie M.R., et al. Morphologic typing of papillary renal cell carcinoma: Comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 32 (2001) 590-595
26. Lubensky I.A., Schmidt L., Zhuang Z., et al. Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. Am J Pathol 155 (1999) 517-526
27. Reuter V., and Tickoo S.K. Adult renal tumors. In: Reuter V. (Ed). Sternberg's Diagnostic Surgical Pathology (2004), Lippincott Williams & Wilkins, Philadelphia, PA 1955-1999
28. Presti Jr. J.C., Rao P.H., Chen Q., et al. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res 51 (1991) 1544-1552
29. Yoshida M.A., Ohyashiki K., Ochi H., et al. Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. Cancer Res 46 (1986) 2139-2147
30. Schmidt L., Junker K., Nakaigawa N., et al. Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene 18 (1999) 2343-2350
31. Dal Cin P., Gaeta J., Huben R., et al. Renal cortical tumors. Cytogenetic characterization. Am J Clin Pathol 92 (1989) 408-414
32. Kovacs G., Wilkens L., Papp T., et al. Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis. J Natl Cancer Inst 81 (1989) 527-530
33. Henn W., Zwergel T., Wullich B., et al. Bilateral multicentric papillary renal tumors with heteroclonal origin based on tissue-specific karyotype instability. Cancer 72 (1993) 1315-1318
34. Ishikawa I., Shikura N., and Ozaki M. Papillary renal cell carcinoma with numeric changes of chromosomes in a long-term hemodialysis patient: A karyotype analysis. Am J Kidney Dis 21 (1993) 553-556
35. van den Berg E., van der Hout A.H., Oosterhuis J.W., et al. Cytogenetic analysis of epithelial renal-cell tumors: Relationship with a new histopathological classification. Int J Cancer 55 (1993) 223-227
36. de Jong B., Molenaar I.M., Leeuw J.A., et al. Cytogenetics of a renal adenocarcinoma in a 2-year-old child. Cancer Genet Cytogenet 21 (1986) 165-169
37. Shipley J.M., Birdsall S., Clark J., et al. Mapping the X chromosome breakpoint in two papillary renal cell carcinoma cell lines with a t(X;1)(p11.2;q21.2) and the first report of a female case. Cytogenet Cell Gener 71 (1995) 280-284
38. Sidhar S.K., Clark J., Gill S., et al. The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet 5 (1996) 1333-1338
39. Takahashi M., Kahnoski R., Gross D., et al. Familial adult renal neoplasia. J Med Genet 9 (2002) 1-5
40. Weterman M.A., van Groningen J.J., den Hartog A., et al. Transformation capacities of the papillary renal cell carcinoma-associated PRCCTFE3 and TFE3PRCC fusion genes. Oncogene 20 (2001) 1414-1424
41. Weterman M.A., van Groningen J.J., Tertoolen L., et al. Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas. Proc Natl Acad Sci U S A 98 (2001) 13808-13813
42. Ladanyi M., Lui M.Y., Antonescu C.R., et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 20 (2001) 48-57
43. Argani P., Antonescu C.R., Illei P.B., et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 159 (2001) 179-192
44. Argani P., Lae M., Hutchinson B., et al. Renal Carcinomas With the t(6;11)(p21;q12): Clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol 29 (2005) 230-240
45. Thöenes W., Baum H.P., Storkel S., et al. Cytoplasmic microvesicles in chromophobe cell renal carcinoma demonstrated by freeze fracture. Virchows Arch B Cell Pathol Incl Mol Pathol 54 (1987) 127-130
46. Thöenes W., Storkel S., Rumpelt H.J., et al. Chromophobe cell renal carcinoma and its variants-A report on 32 cases. J Pathol 155 (1988) 277-287
47. Storkel S., Steart P.V., Drenckhahn D., et al. The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct. Virchows Arch B Cell Pathol Incl Mol Pathol 56 (1989) 237-245
48. Akhtar M., Tulbah A., Kardar A.H., et al. Sarcomatoid renal cell carcinoma: The chromophobe connection. Am J Surg Pathol 21 (1997) 1188-1195
49. Tickoo S.K., Amin M.B., and Zarbo R.J. Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma: Emphasis on technique and patterns of staining. Am J Surg Pathol 22 (1998) 419-424
50. Weiss L.M., Gelb A.B., and Medeiros L.J. Adult renal epithelial neoplasms. Am J Clin Pathol 103 (1995) 624-635
51. Bugert P., Gaul C., Weber K., et al. Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. Lab Invest 76 (1997) 203-208
52. Schwerdtle R.F., Storkel S., Neuhaus C., et al. Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma. Cancer Res 56 (1996) 2927-2930
53. Kovacs A., and Kovacs G. Low chromosome number in chromophobe renal cell carcinomas. Genes Chromosomes Cancer 4 (1992) 267-268
54. Akhtar M., Al-Sohaibani M.O., Haleem A., et al. Flow cytometric DNA analysis of chrmophobe cell carcinoma of the kidney. J Urol Pathol 4 (1996) 15-23
55. Kovacs A., Storkel S., Thoenes W., et al. Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas. J Pathol 167 (1992) 273-277
56. Crotty T.B., Farrow G.M., and Lieber M.M. Chromophobe cell renal carcinoma: Clinicopathological features of 50 cases. J Urol 154 (1995) 964-967
57. Motzer R.J., Bacik J., Mariani T., et al. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol 20 (2002) 2376-2381
58. Amin M.B., Crotty T.B., Tickoo S.K., et al. Renal oncocytoma: A reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am J Surg Pathol 21 (1997) 1-12
59. Lieber M.M., Tomera K.M., and Farrow G.M. Renal oncocytoma. J Urol 125 (1981) 481-485
60. Perez-Ordonez B., Hamed G., Campbell S., et al. Renal oncocytoma: A clinicopathologic study of 70 cases. Am J Surg Pathol 21 (1997) 871-883
61. Tickoo S.K., and Amin M.B. Discriminant nuclear features of renal oncocytoma and chromophobe renal cell carcinoma: Analysis of their potential utility in the differential diagnosis. Am J Clin Pathol 110 (1998) 782-787
62. Tickoo S.K., Lee M.W., Eble J.N., et al. Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma. Am J Surg Pathol 24 (2000) 1247-1256
63. Erlandson R.A., Shek T.W., and Reuter V.E. Diagnostic significance of mitochondria in four types of renal epithelial neoplasms: An ultrastructural study of 60 tumors. Ultrastruct Pathol 21 (1997) 409-417
64. Rumpelt H.J., Storkel S., Moll R., et al. Bellini duct carcinoma: Further evidence for this rare variant of renal cell carcinoma. Histopathology 18 (1991) 115-122
65. Singh I., and Nabi G. Bellini duct carcinoma: Review of diagnosis and management. Int Urol Nephrol 34 (2002) 91-95
66. Füzesi L., Cober M., and Mittermayer C. Collecting duct carcinoma: Cytogenetic characterization. Histopathology 21 (1992) 155-160
67. Adsay N.V., deRoux S.J., Sakr W., et al. Cancer as a marker of genetic medical disease: An unusual case of medullary carcinoma of the kidney. Am J Surg Pathol 22 (1998) 260-264
68. Avery R.A., Harris J.E., Davis C.J., et al. Renal medullary carcinoma: Clinical and therapeutic aspects of a newly described tumor. Cancer 78 (1996) 128-132
69. Davis C.J., Mostofi F.K., and Sesterhenn I.A. Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol 19 (1995) 1-11
70. Swartz M.A., Karth J., Schneider D.T., et al. Renal medullary carcinoma: Clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications. Urology 60 (2002) 1083-1089
71. Storkel S., Eble J.N., Adlakha K., et al. Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80 (1997) 987-989
72. Zisman A., Chao D.H., Pantuck A.J., et al. Unclassified renal cell carcinoma: Clinical features and prognostic impact of a new histological subtype. J Urol 168 (2002) 950-955
73. Bugert P., and Kovacs G. Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis. Am J Pathol 149 (1996) 2081-2088
74. Steiner G., and Sidransky D. Molecular differential diagnosis of renal carcinoma: From microscopes to microsatellites. Am J Pathol 149 (1996) 1791-1795
75. Wagner J.R., and Linehan W.M. Molecular genetics of renal cell carcinoma. Semin Urol Oncol 14 (1996) 244-249
76. Richards F.M., Payne S.J., Zbar B., et al. Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Hum Mol Genet 4 (1995) 2139-2143
77. Poston C.D., Jaffe G.S., Lubensky I.A., et al. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: Clinical and molecular genetic implications. J Urol 153 (1995) 22-26
78. Linehan W.M., Lerman M.I., and Zbar B. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer. JAMA 273 (1995) 564-570
79. Suzuki H., Ueda T., Komiya A., et al. Mutational state of von Hippel-Lindau and adenomatous polyposis coli genes in renal tumors. Oncology 54 (1997) 252-257
80. Zbar B., Tory K., Merino M., et al. Hereditary papillary renal cell carcinoma. J Urol 151 (1994) 561-566
81. Zbar B., Glenn G., Lubensky I., et al. Hereditary papillary renal cell carcinoma: Clinical studies in 10 families. J Urol 153 (1995) 907-912
82. King C.R., Schimke R.N., Arthur T., et al. Proximal 3p deletion in renal cell carcinoma cells from a patient with von Hippel-Lindau disease. Cancer Genet Cytogenet 27 (1987) 345-348
83. Jordan D.K., Patil S.R., Divelbiss J.E., et al. Cytogenetic abnormalities in tumors of patients with von Hippel-Lindau disease. Cancer Genet Cytogenet 42 (1989) 227-241
84. Goodman M.D., Goodman B.K., Lubin M.B., et al. Cytogenetic characterization of renal cell carcinoma in von Hippel-Lindau syndrome. Cancer 65 (1990) 1150-1154
85. Bodmer D., van den Hurk W., van Groningen J.J., et al. Understanding familial and non-familial renal cell cancer. Hum Mol Genet 11 (2002) 2489-2498
86. Schmidt L., Duh F.M., Chen F., et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16 (1997) 68-73
87. Zbar B., Alvord W.G., Glenn G., et al. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome. Cancer Epidemiol Biomarkers Prev 11 (2002) 393-400
88. Khoo S.K., Giraud S., Kahnoski K., et al. Clinical and genetic studies of Birt-Hogg-Dube syndrome. J Med Genet 39 (2002) 906-912
89. Pavlovich C.P., Walther M.M., Eyler R.A., et al. Renal tumors in the Birt-Hogg-Dube syndrome. Am J Surg Pathol 26 (2002) 1542-1552
90. Teh B.T., Blennow E., Giraud S., et al. Bilateral multiple renal oncocytomas and cysts associated with a constitutional translocation (8;9)(q24.1;q34.3) and a rare constitutional VHL missense substitution. Genes Chromosomes Cancer 21 (1998) 260-264
91. Avery A.K., Beckstead J., Renshaw A.A., et al. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 24 (2000) 203-210
92. McGregor D.K., Khurana K.K., Cao C., et al. Diagnosing primary and metastatic renal cell carcinoma: The use of the monoclonal antibody 'renal cell carcinoma marker'. Am J Surg Pathol 25 (2001) 1485-1492
93. Mathers M.E., Pollock A.M., Marsh C., et al. Cytokeratin 7: A useful adjunct in the diagnosis of chromophobe renal cell carcinoma. Histopathology 40 (2002) 563-567